Table 2.
Smoking Outcome Measures
| Abstinence measure | Placebo (N = 22) | Varenicline (N = 25) | t | Significance (p) |
| Days of continuous abstinence, M (SD) | 9.1 (9.7) | 16.4 (11.3) | −2.36 | .02 |
| Participants continuously abstinent, n (%) | 3 (13.6) | 10 (40.0) | a | .05 |
| Number of negative samples, M (SD) | 2.1 (2.5) | 4.1 (3.0) | −2.43 | .02 |
| Hours abstinent after lapse exposure, M (SD) | 148 (229) | 336 (290) | −2.44 | .02 |
Note. aFisher’s exact test